Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968822 · ClinicalTrials.gov registry record · Phase 4
Intralipid® 20% for Reversal of Local Anesthetics
A Phase 4 study of Anesthesia, Local, sponsored by Hospital for Special Surgery, New York.
- Active
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT03968822 is a Phase 4 study of Anesthesia, Local that is active but no longer recruiting, run by Hospital for Special Surgery, New York. The registered enrollment target is 18 participants, below the 82-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03968822, a Phase 4 study of Anesthesia, Local, is active but no longer recruiting, sponsored by Hospital for Special Surgery, New York.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
In order to determine if Intralipid 20% can be used to reverse the effects of local anesthetics, the investigators will recruit 18 volunteers who will be asked to come to HSS for two study visits. Small amounts of local anesthetics will be injected into the volunteers' thighs during both visits. During one visit volunteers will receive Intralipid 20% and during the other visit they will receive a saline solution. The study team will measure how quickly normal sensation returns to the thighs when the volunteers get Intralipid 20% compared to saline.
Conditions Studied
Interventions
- DRUG Lidocaine 2%
- DRUG Lidocaine 1%
- DRUG Bupivacaine 0.25%
- DRUG Bupivacaine 0.5%
- DRUG Intralipid, 20% Intravenous
Study Locations (1)
New York
- Hospital of Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-07-26 |
| Est. Completion | 2026-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03968822
The ClinicalTrials.gov registry entry for NCT03968822 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (78% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 5 interventions - of which Lidocaine 2% is the first listed.
NCT03968822 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03968822 about?
NCT03968822 is a clinical study titled "Intralipid® 20% for Reversal of Local Anesthetics". In order to determine if Intralipid 20% can be used to reverse the effects of local anesthetics, the investigators will recruit 18 volunteers who will be asked to come to HSS for two study visits. Small amounts of local anesthetics will be injected into the volunteers' thighs during both visits. Dur...
What is the current status of trial NCT03968822?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2019-07-26. Estimated completion is 2026-10.
What conditions does trial NCT03968822 study?
This clinical trial studies the following conditions: Anesthesia, Local.
What interventions are being tested in trial NCT03968822?
The interventions under investigation include: Lidocaine 2% (DRUG), Lidocaine 1% (DRUG), Bupivacaine 0.25% (DRUG), Bupivacaine 0.5% (DRUG), Intralipid, 20% Intravenous (DRUG).
Who is sponsoring clinical trial NCT03968822?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03968822 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
-
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
RECRUITING · Phase 4
-
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
COMPLETED · Phase 4
-
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.